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We have prepared extracts from cycloheximide-treated cellsfor the study of simian-virus-40 (SV40)-DNA replication i vitro. When supplemented 
with the viral initiator protein (large T antigen), these extracts fully supported SV40-DNA replication. We also determined that SV40-DNA 
replication i  vivo is much more resistant to cyclohenimide than cellular DNA replication. SV40 encodes its own initiator protein, T antigen, which 
also functions as a DNA helicase, but depends on cellular functions for all additional replication reactions. Therefore, itappears to be quite likely 
that cycloheximide affects cellular DNA replication by blocking the synthesis of (a) cellular function(s) that is(are) performed by T antigen in 
SV40-DNA replication. Indeed, DNA fiber autoradiography and alkaline sucrose gradient centrifugation f pulse-lal~l~ cellular DNA showed 
that eycloheximide treatment almost completely suppressed rcplicon initiation and reduced the rate of replication fork movement to about one 
third of the control. 
1. INTRODUCTION 
It has been known for two decades that mammalian 
DNA replication depends on ongoing protein synthesis. 
This conclusion is based on observations showing that 
cycloheximide and other drugs, interfering with protein 
synthesis, cause a rapid reduction of [~H]thymidine in- 
corporation into the DNA of proliferating mammalian 
cells in culture. Since translation inhibitors of different 
structures and different mechanisms of action have 
identical effects on DNA replication it appears to be 
highly unlikely that essential replication proteins are 
directly affected, e.g. by protein-bound drugs. Early ex- 
periments had also e~cluded the possibility that eyclo- 
heximide and related drugs may affect cellular nu- 
cleotide metabolism. Therefore, the inhibition of DNA 
replication by cycloheximide and other translation inhi- 
bitors are best explained by assuming that one or more 
essential replication factors are rapidly inactivated or 
degraded, and that these factors have to be synthesized 
de novo to allow DNA replication to continue [1,2]. 
Recent e>~periment~ have shown that translation inhi- 
bitors induce the expression of certain genes. However, 
it is unlikely that this could play a part in replication 
inhibition since at least 100-fold higher drug concentra- 
tions are needed to effectively block protein s~,'nthesis 
and DNA replication [3]. 
The nature of the replication factors that are either 
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inactive or missing in drug-treated cells is presently un- 
known. However, with the establishment of assays for 
the cell-free replication of SV40-DNA [4] it is now pos- 
sible to reinvestigate his problem. 
In these in vitro assays, protein-free viral DNA or 
plasmid DNA, carrying the SV40 origin of replication 
[4], as well as SV40 minichromosomes [5-7] are repli- 
cated by a classical semiconservative mechanism; DNA 
replication is initiated at a fixed origin of  replication 
where two replication forks are established which then 
proceed bidirectionally to meet each other at a termina- 
tion site just opposite on the circular DNA template. 
These reactions require only one virus-encoded protein, 
large T antigen, whereas all other functions are pro- 
vided by a protein extract from proliferating 'permis- 
sive' human cells (reviewed in [8,9]). 
T antigen binds specifically to sequence, motifs in the 
SV40 origin of replication where it induces a conforma- 
tional change in the double helix, In the presence of 
ATP hydrolysis, T antigen unwinds the complementary 
DNA strands at the origin and then serves as a helicase 
to propagate replication forks (reviewed in [10]). 
All other reactions, required for SV40 DNA replica- 
tion, are performed by cellular proteins. These include 
the DNA polymerase a:-primase complex for lagging 
and the DNA polymerase 3 for leading strand synthesis 
0s well as several auxiliary factors such as the 'proli- 
ferating cell nuclear antigen' (PCNA) and replication 
factor C (RF-C). Additional essential cell proteins are 
the human single-strand-specific binding protein 
(replication factor A, RF-A), DNA topoisomerases, 
RNase H and ligase (for recent reviews, see [! !,12]). 
If one of these proteins were missing or inactive in 
extracts, prepared from cells treated with the translation 
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Fig. 1, Extracts from CHX-treated HeLa cells support origin-dependent DNA replication in vitro. (A) Pulse.label with [‘Hlthymidine. We present 
an experiment with 20 PM CHX, added al I = 0 min. to proliferating HcLa cells. The data, obtained with 50 and IOfJpM CHX, were virtually 
identical (not shown). (6) DNA replication in vitro. Incubations were performed using 100 ng pSVMOl-DNA, about 250 ng cellular proteins and 
I pg purified T antigen in 0.05 ml reaction volumes. Control incubations were performed in parallel assays in the absence of T antigen. Aliquots 
of5 ~1 were removed at the indicated times (min, abscissa) to determine the incorporated radioactivity by acid precipitation. The remainder of 
the samples were processed ror rgarose gel electrophoresis (see Fig. 2). 
inhibitor cycloheximide (CHX), the chain elongation 
reaction in the in vitro SV40-DNA replication assay 
would be impossible. On the other hand, if replication 
proceeded undisturbed in extracts from CHX-treated 
cells, it would be concluded that, in the in vitro system, 
T antigen replaces the cellular protein(s) the amount or 
activity of which is limited in CHX-treated cells. In this 
case, we would also expect that CHX has less severe 
effects on SV40 DNA replication in vivo as it is known 
that the nuclei of SV40-infected cells contain hish 
amounts of T antigen. The experiments, reported in tiis 
communication, were performed to investigate these 
possibilities. 
2. MATERIALS AND METHODS 
Human HeLa cells (American Type Culture Collection CCL 2.21 
wcrc used for the preparation of cell extracts. The TC7 sublins of 
monkey CVI cells (American Type Cuhure Collection CCL70) was 
used for viral i&ctioo. The cells were grown on plastic dishes in 5% 
fetal calf serum under standard cell culture conditions. Infection with 
SV40 and DNA exrraction has been described before [131. Uninfected 
HeLa or C’J I cells at 24 h after inf=tiou were labeled with 0.04 yCi 
[‘%]thymidine (Amersham) for lo-16 h (long-ten label). Medium 
was then removed and replaced by 2 ml fresh medium (plus 5% fetal 
calfscrca)* containing CHX in the concentrations given below, After 
various times in CHX. pulse-labeling was performed by the addition 
of lO+Ziiml [“Hlthymidine for S-IO min. The cells were then washed 
with ice-cold phosphate-buffered saline and collected in the same 
burer before lysis in 0.5% sodium dodecylsulfatc and precipitation or 
DNA by trichloroacetic acid. Viral DNA was extracted by the Hirt 
procedure [ 141 and precipitated by trichloroacelic acid. The long-term 
Y-label served as an internal standard. Labeled cellular DNA was 
investigated by alkaline sucrose gradient sedimentalion as previously 
described [l8], Pulse-labeled viral DNA was denatured in 0.1 M 
NaOH and also analyzed by alkaline sucrose gradient scdimcntation 
1131. 
2.2. SV40 DNA rcpficariolt in vitro 
Protein extracts were prepared from untreated and CHX-treated 
HeLa cells as describeti in [4] with minor modifications [7]. T antigen 
was purified from crude extracts by an immunoz&lnity procedure [16]. 
As a template for in vitro DNA replication, we used plasmid pSVMO- 
I. a pUC?+dcrivativc carrying the SV40 origin of replication (SV40 
nuclcotide coordinates: 5171 to 42). Replication was performed ac- 
cording to published procedures [4.7] using [o-“?P]dATP as a radioac- 
tive tracer. The replication products were purified from the reaction 
mixture and investigated by agarose gel electrophoresis and auto- 
radiography [7]. 
2.3. DNA jber autoradiogr’uphy 
Untreated and, in parallel rxperinents, CHX-treated H&a cells (2 
x IO’ c&/35-mm dish) were incubated in I ml prewarmud medium 
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with 1 BM [3H]thymidine (methyl-[3H]; 82 Ci/mmol, Amersham) ('hot 
pulse'). After 20 rain, a "warm pulse' was started by the addition of 
non-radioactive thymidine to dilute the specific radioactivity to 1/10, 
After an additional 20 rain incubation period, the cells were washed 
with phosphate-buffered saline, trypsinized and processed for auto. 
radiography as previously described [17]. After a 6-month exposition, 
the autoradiographs were developed and evaluated as described [1B], 
3. RESULTS AND DISCUSSION 
3.1. Replication efficiencies ofprotein extracts prepared 
from CHX-treated cells 
We used CHX at concentrations between 10 and 100 
/~M CHX which are sufficient o reduce the rate ef 
protein synthesis within 10 rain to less than 1% of the 
control as determined by [-a~S]methionine or [3H]leucine 
incorporation ( ot shown)• As demonstrated in Fig. 1, 
the rate of [~H]thymidine incorporation into cellular 
DNA also rapidly decreased to 10% or less of the con- 
trol value. Similar data were obtained using 80/zM 
puromycin as the protein inhibitor (not shown). 
Protein extracts were prepared from normal and from 
CHX-treated HeLa cells [4]. These extracts we~'e added 
to assay mixtures containing purified T antigen and, as 
a template, plasmid pSVMO1, carrying the SV40-ori- 
gin. Incubation at 37°C revealed that the incorporation 
of 3ap-labeled nucleotides into acid precipitable material 
was identical regardless of whether the protein extracts 
were prepared from untreated cells or from cells, treated 
with CHX for different lengths of times or at different 
drug concentrations (Fig. 1). 
It is unlikely that the in vitro DNA synthesis observed 
was due to repair since the incorporation of ~-'P-!abeled 
nucleotides depended on T antigen (Fig. 1) and required 
the SV40 origin of replication as plasmids without the 
viral origin were inactive as templates for in vitro 
replication (not shown; see [4]). 
However, to clearly demonstrate that replication was 
identical in extracts from untreated and CHX-treated 
cells we isolated the in vitro synthesized "a-'P-labeled 
DNA for analysis by agarose gel electrophoresis and 
autoradiography. As demonstrated in Fig. 2, radioac- 
tively labeled material appeared after 15 min incubation 
time as slowly migrating replicative intermediates and, 
at later times, as closed circular form 11 DNA in relaxed 
and slightly superhelical configuration. In addition, we 
observed in these (and other similarly performed) ex- 
periments a large fraction of radioactivity in slowly 
migrating, large DNA structures. These forms include 
replicative intermediates and catenated DNA forms as 
well as rolling circle type intermediates [7] which may 
arise after artefactual breakage of one fork of in vitro 
replicating DNA. 
For the present discussion, it is important to note that 
the replication products were very similar for extracts 
from untreated and from CHX-treated cells. 
Thus, all cellular replication elongation functions, 
known to be essential for SV40 DNA replication in 
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Fig. 2. Replication products, synthesized with extracts from untreated 
and from CHX-treated HeLa c~lls, Aliquots w~re removed at the 
indicated times from in vitro assay mixtures and treated first with 
RNase A (100/a~/ml) and then with proteinase K (100/~g/ml) before 
the DNA was purified by extraction with phenol and chloroform. The 
DNA was precipitated twice with ethanol and analys~ on 1% agarose 
gels and autoradiography, (A) DNA synth~is in extracts, prepared 
from m~treatc~d HeLa cells; (B) DNA synthesis in extracts, prepared 
from cells, treated for 30 rain with 20 #lVl CHX (see Fig. 1 ). In vitro 
replication tirn~ (in rain) are indicated. The results ofcontrol incuba- 
tions (120 rain in the absence o f t  antigen) are also shown (-T-ag). 
The electrophoresis markers (M) are nicked circular (form II) and 
linear (form Ill) pSVMOI DNA. 
vitro, are quire active in extracts from CHX-treated 
cells. Similar data were obtained using puromycin 
which inhibits protein synthesis by an entirely different 
mechanism (not shown). 
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Fig. 3. Effect of CHX on SV40 DNA replication in v’xo. SV40- 
infected CVl cells were long-term labeled with [‘%‘I]thymidine, treated 
with 30 PM CHX and pulse-labeled with [‘Hlthymidine al the times 
indicated. SV40-DNA was extracted by the Hirt procectiure, xid- 
precipitated and counted (0). For comparison, we show thi: results of 
a parallel experiment, measuring the incorporation of pulse-label inu 
the DNA of uninfected cells (0). 
A prediction, derived from the data of Figs. I and 2, 
is that SV40 DNA replication in vivo should be less 
vulnerable to CHX treatment than celluhv DNA 
replication because nuclei of SV40-infected ceils contain 
high amounts of T antigen. The experiments, reported 
in the next section, were performed to investigate this 
possibility. 
3.2. Effeecrs of CHX otz SV40-DNA replication in vivo 
As described above [Fig. I), the rate of cellular DNA 
synthesis, determined by pulse-labeling with [‘HIthy- 
midine, decreases to less than 10% within 10 min after 
addition of CHX. In contrast, SV40-DNA replication 
was found to be far less sensitive to CHX; incorporation 
of [3H]thymidine decreased to only 70% and 50% of the 
control at 30 and 60 min after addition of CHX, respec- 
tively; and even at 120 min, the rate of ‘” incorporation 
was still about 20% of the control (Fig. 3). 
To determine whether the mode of SV40-DNA 
replication changes in the presence of CHX, we inves- 
tigated the structure of pulse-labeled SV40-DNA by 
alkaline sucrose gradient sedimentation. Under these 
conditions, mature covalently closed SV40-DNA sedi- 
ments as a random coil with >50 S whereas nicked 
circular and replicative intermediate DNA is denatured 
to give linear DNA strands of different lengths. Using 
this technique, we were unable to detect significant dif- 
ferences between the structures of pulse-labeled SV40- 
DNA, synthesized before and at increasing times after 
addition of CHX (Fig. 4). An interesting, but unex- 
plained observation was that the fraction of pulse- 
labeled DNA, appearing in mature, fast sedimenting 
supercoiled DNA, increased from 6% to about 14% of 
total incorporated radioactivity upon treatment with 
CHX (Fig. 4). 
In sum, the results of the in vivo experiments show 
that SV40 DNA replication is far less sensitive to CHX- 
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Fig. 4. Anaiysis ol’SV40-DNA by alkaline sucrose gradient centril’ugation. SV?O-DNA was long-term labeled with [“C]thym:dine and pulsc.labcled 
with [“H]thymidine before and at the indicated times arter addition of CHX as dctisribcd in szction 2. Hundred-percent values are: I%, cd. 1200 
cpm; ‘H, 181,000 cpm (control); 155,000 cpni (10 min in CHX:r: 135,000 cpm (20 min); I lO.OOU cl?m (30 loin); and 68,000 cpm (40 min). The table 
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Fig. 5. Alkaline sucrose gradient sedimentation of labeled celi~lar DNA strands in untreated and CHX-treated HcLa cells. Untreated and 
CHX-treated (30 PM) HeLa cells were pulse-labelled for 8 min with [“Hlthymidinc. The cells were washed with cold phosphate-buffered saline, 
trypsinized and lysed on top of an alkaline sucrose gradients which were made up and centrifuged exactly as described [21]. Direction of 
sedimentation is from the right to the left. “C-labeled phagc A DNA served as a marker (37-40 S) (not shown). (A) Untreated control (0); 2 h 
after CHX (m); 2 h in CHX, followed by 40 min in CHX-free medium (A). The ordinate gives the percentage of recovered radioactivity. The total 
radioactivity was: untreated control, I83,600 cpm; _ 7 h in CHX, 12,630 cpm; 40 min recovery after CHX-treatment. 76,100 cpm. (6) Data of (A) 
were multiplied by the quotient of the (separately determined) rates of DNA synthesis in CHX-treated and control cells. Sedimentation was from 
the right to the left. 
treatment han cellular DNA replication. The most 
likely reason for this is the high concentration of T 
antigen, the viral initiator protein, in the nuclei of in- 
fected cells. 
However, T antigen is subjected to post-translational 
modifications; and it is kncwn that highly phospho- 
rylated ‘old’ T antigen is unable to properly bind to the 
viral origin and to induce replication (reviewed in [19]). 
Thus, in the presence of CHX, the synthesis of new and 
repiication-competent T antigen is prevented, and 
stored T antigen is inactivated by phosphorylation. This 
explains why the rate of SV40-DNA replication slowly 
decreased with time after addition of CHX. 
In general, however, the results of the in vivo experi- 
ments agree with those obtained from DNA replication 
in vitro. They suggest that replication elongation func- 
tions are not depleted in CHX-treated cells. Since both 
viral and cellular DNA replication depend on the same 
set of replicat:on functions, it appears that the lack of 
(an) active cellular initiator(s) may be responsible for 
the drastic effects of CHX on cellular DNA replication. 
3.3. CelM~r DIVA replication in CHX-treated cells 
As a first attempt to determine the nature of this 
function, we used DNA fiber autoradiography [20] to 
investigate the frequency of ceiiuiar replication iniiia- 
tion events and the fork movement rate in untreated and 
CHX-treated HeLa cells [ 181. 
The relative frequency of replication initiation [18,22] 
was determined as the ratio of the number of grain 
pattern indicative of initiation within the 20-min ‘hot’ 
labeling period and the number of post-initiation grain 
pattern (Table I). We found a reduction of this ratio 
from 1.44 before to 0.09 after CHX-treatment showing 
that replicon initiation was severely inhibited in CHX- 
treated HcLa cells. The fork movement rate, determined 
as the lengths of the autoradiographic silver grain 
tracks, was also reduced from 0.86 ymlmin in normal 
to 0.3 pumlmin in CHX-treated cells. However, the 
arrangement of active replicons along the parental 
Table I 
Results of DNA fiber autoradiography 
Control 10 min CHX 
Relative initiation 
frequency* 
Fork movement rate 
WrnImin) 
1.44 
rI = 523 
mean = 0.86 
n = 427 
SD. = 0.31 
inter-initiation 
distana: @m) 
mean = 67.0 
n = 172 
S.D. = 3l.S 
0.09 
II = 199 
mean = 0.30 
n = 357 
S.D. = 0.12 
mean = 44.9 
n = 75 
S,D. = 30.3 
Post-pulse initiation pattcm, --U--; pre-pulse inidalion pattern, 
-I I-. 6 The ‘relative imtiation frequency’ isthe rdlio ofpost-pulse 
ini::istion lo pre-pulse initiation pattern. 
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DNA as represented by inter-initiation distances 
appeared not to be significantly affected by CHX (Table 
I) suggesting that clusters of replicons fail to be si- 
multaneously activated in CHX-treated cells. 
The autoradiographic data were supported by the 
results of an entirely different approach, the analysis of 
chain length distribution by alkaline sucrose gradient 
sedimentation [21]. In untreated control cells, most of 
the DNA strands, pulse-labeled with [3H]thymidine for 
8 min, sedimented with a peak at about 40 S (Fig. 5). 
After CHX treatment, the amount of incorporation of 
[3H]thymidine-labeled DNA strands was drastically re- 
duced as expected (see Fig. 1). However, the residual 
radioactivity appeared in DNA strands that were 
clearly longer than the DNA strands, made in the 
absence of CHX, suggesting a continued growth of in- 
itiated DNA strands and a reduction of initiation 
events. This is not due to a general toxic effect on cell 
metabolism since [“Hlthymidine-labeled 40 S DNA 
strands reappeared soon after removal of CHX (Fig, S) 
indicating that new replicons were reinitiated. 
Thus, the results of both experiments, fiber auto- 
radiography and alkaline sucrose gradient centrifuga- 
tion, suggested an almost complete block of replication 
initiation. In addition, fiber autoradiography indicated 
a reduced fork movement rate in HeLa cells as noted 
before by others [1,2]. Interestingly, in Ehrlich ascites 
cells, suppression of initiation appears to be the only 
response of the replication machinery to CHX treat- 
ment [15]. 
4. CONCLUSION 
Our data show that cellular functions, responsible for 
replicative chain elongation in the in vitro SV40 replica- 
tion system, remain active after treatment of Heka cells 
with CHX. In addition, SV40 DNA replication in vivo 
is far less sensitive to CHX-treatment than cellular 
DNA replication. Except for the virus-encoded, T-anti- 
gen-associated DNA hclicase, the viral and the cellular 
replication apparatus hare the same group of elonga- 
tion functions. Therefore, the reduction of cellular 
DNA replication in CHX-treated cells is best explained 
assuming that cellular functions, responsible for the in- 
itiation of replication, are absent or inactive in these 
cells. 
Indeed, fiber autoradiography demonstrated an 
almost complete block of replication initiation, and, in 
addition, a reduced fork movement rate in HeLa cells. 
It will be noted that these two activities, an activation 
of origins and the propagation of replication forks, are 
performed by T antigen in SV40 DNA replication, And 
it is an intriguing possibility that the CHX-sensitive 
cellular function rnay be a celiular counterpart of T 
antigen. 
154 
However, since almost nothing is known about the 
nature of cellular initiator proteins we can only specu- 
late about possible mechanisms of their inactivation 
after CHX treatment, The proteins could be degraded, 
or they could be sequestered by being tightly bound to 
DNA sites in the origin or in the termination region of 
a replicon where they remain unavailable for the activa- 
tion of origin sequences in other replicons, It is also 
possible that the proteins are inactivated by modifica- 
tions. The inactivation of T antigen by hyperphos- 
phorylation may serve as an example [19]. In any case, 
our experiments have implications for a further analysis 
of the mammalian replication machinery as the con- 
centration of active initisi-or proteins may be quite low 
and difficult to investigate by standard biochemical pro- 
cedures. 
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